Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NCT02460588Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide in idiopathic pulmonary fibrosis (IPF), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2015; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT02460588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02460588.